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Objective. To evaluate the degree of axial elongation with soft radial refractive gradient (SRRG) contact lenses, orthokeratology
(OK), and single vision (SV) spectacle lenses (control) during a period of 1 year before treatment and 2 years after treatment.
Methods. This was a prospective, longitudinal, nonrandomized study. The study groups consisted of 30, 29, and 41 children,
respectively. The axial length (AL) was measured during 2 years after recruitment and lens fitting. Results.The baseline refractive
sphere was correlated significantly (r2 = 0.542; P < 0.0001) with the amount of myopia progression before baseline. After 2 years,
the mean myopia progression values for the SRRG, OK, and SV groups were −0.56 ± 0.51, −0.32 ± 0.53, and −0.98 ± 0.58 diopter,
respectively. The results represent reductions in myopic progression of 43% and 67% for the SRRG and OK groups, respectively,
compared to the SV group. The AL increased more in the SV group compared to the SRRG and OK groups, with 27% and 38%
lower axial elongation, respectively, compared to the SV group at the 2-year visit (P < 0.05). SRRG and OK showed no differences
(P = 0.430). Conclusion. The SRRG lens significantly decreased AL elongation compared to the SV control group. The SRRG lens
was similarly effective to OK in preventing myopia progression in myopic children and adolescent.
1. Introduction
Myopia is associated with ocular complications that can
lead to permanent vision loss [1]. This is especially true in
relation to the amount of refractive error that is related to
an increased risk of retinal detachment, glaucoma, cataract,
and chorioretinal degeneration as the leading causes of
permanent visual impairment [2].
Studies of the emmetropization mechanism in animals
have suggested that treatments that consider the peripheral
retinamay bemuchmore effective than others [3]. In particu-
lar, experiments inmonkeys have indicated that visual signals
from the peripheral retina are essential for several aspects of
regulation of vision-dependent ocular growth [4]. Moreover,
recent studies have shown that inducing a multifocal image
on the eye and moving the image forward at the peripheral
retina, leaving it myopically defocused, generates a visual
stimulus to slow ocular growth [5, 6].
Several strategies using optical devices have been devel-
oped to reducemyopic progression.Undercorrection actually
accelerates myopia progression [7]. Progressive addition
lenses have a significant but clinically small effect [8, 9] that
is potentially related to changes in defocus of superior retinal
images [10]. Bifocal executive lenses have shown significant
and promising results especially in esophoric children and
those with rapid progression [11]. An experimental spectacle
lens designed to decrease peripheral hyperopia reduced
myopic progression by 30% over a 12-month period [12].
Rigid gas permeable contact lenses also have a small effect
that can be confounded by the keratometric changes [13].
Orthokeratology (OK) slows axial elongation of the eye
by about 50% [14] and is the current technique with the
most consistent results, except in low myopes with less than
2 BioMed Research International
−2.00 diopters (D), in whom this therapy seems to have less
benefit according to one study [15]. This finding is likely
related to the fact that the change in corneal curvature
is lower in these patients and results in less peripheral
myopization. The induced peripheral myopia regarding the
spherical equivalent has an almost 1 : 1 relationship with the
amount of baseline spherical equivalent refraction to be
corrected [16]. Although some investigators have attempted
to overcome this limitation, they were unsuccessful [17]. For
myopia exceeding −6.00D, the treatment is unapproved in
some countries, and usually the fit is muchmore challenging.
In addition, due to particular ocular characteristics, not all
patients are candidates.
Softmultifocal contact lenses are advantageous compared
to ophthalmic lenses because they move with the eye and
thus the optical correction remains centered for all gaze
positions. Previous studies of multifocal contact lenses have
reported reductions in myopic progression ranging from
30% to 50% and about 30% in axial length (AL) depending
on lens design [18–22]. Generally, all experimental lenses
tested were designed with a central optic zone intended for
distance vision and surrounded by one or more rings with
adequate plus addition powers. Further, previous works have
shown reductions in the ocular growth rate in eyes fitted
with multifocal soft contact lenses compared with monofocal
contact lenses or spectacle controls. In the current study, we
evaluated an experimental SRRG contact lens designed to
correct the central refraction and simultaneously produce
constant peripheralmyopization defocus that increased grad-
ually from the central optic axis toward the periphery. The
details of the optical design were reported elsewhere [23, 24].
Since previous studies have demonstrated that peripheral
refraction can be changed towards a relative peripheral
myopic condition using orthokeratology [16, 17] or peripheral
gradient contact lenses [18, 23, 24], the primary goal of
the current study was to investigate the myopic control
effect of the SRRG experimental lens. A second goal was
to compare its efficacy with that of OK, the current golden
standard in myopia control with contact lenses. To the best
of our knowledge, this is the first controlled clinical trial to
provide information about myopic progression 12 months
before entry into the study, compare the efficacy of two
treatments with different contact lenses, and present insight
into the potential causes of myopia control by analyzing the
peripheral refraction.
2. Materials and Methods
2.1. Participants. Three study groups were recruited for this
trial from 127 Caucasian clinical patients at the Centro
Me´dico Teknon. The participants were recruited from May
2011 to September 2012. The Ethics Committee for Clinical
Research of Centro Me´dico Teknon approved the study
protocol, which adhered to the tenets of the Declaration
of Helsinki. All parents provided signed consent for their
children to participate. The inclusion criteria were ages from
9 to 16 years at the baseline visit, spherical refractive error
between −0.75 and −7.00D, less than −1.25D of astigmatism
measured by cycloplegic autorefraction, a best spectacle-
corrected visual acuity of 20/20 or better in each eye, and
a minimal increase in myopia of −0.30D/year from 1 year
before the start of the study. The same instrument and
examiner provided the previous cycloplegic autorefraction
performed at least 1 year before study entry. A regression line
was fitted to the data to calculate the slope of the annual
increase in myopia. The maximal annual myopia refractive
increase of the participantswas−1.29D.The exclusion criteria
were anisometropia exceeding 1.00D, strabismus, and any
systemic or ocular disease that may affect ocular growth or
contact lens wear.
Of the 127 subjects recruited, 27 were excluded for
not having the minimal annual myopia progression of
−0.30D/year. The final study groups included 30 children in
the soft SRRG group, 29 in the OK group, and 41 in the single
vision spectacle lenses (SV) group.
2.2. Sample size. The sample size was calculated to determine
whether the patients in the SRRG and OK groups progressed
slower than those in the SV group. The standard deviations
(SDs) of the 2-year changes in AL and refractive error were
assumed to be 0.15mm and 0.50D, respectively. To have 80%
power (𝛼 = 0.05) with a confidence level of 95% to detect a
difference of 0.15mm and 0.50D over 2 years, the minimal
numbers of subjects required in each group were 19 and 17,
respectively.
2.3. Study Design. This was a prospective, longitudinal,
nonrandomized study. After receiving an explanation of the
study, the parents chose the treatment for their child. The
AL and refraction were obtained without correction in all
groups every 6 months over 2 years. Soft contact lens wearers
were instructed to not wear the lenses for 2 days before
the follow-up examinations to avoid any potential corneal
warpage that might induce errors in the estimation of the
refractive error. The main outcomes of efficacy of myopic
control were determined by comparing the differences in the
mean changes in AL and spherical equivalent (M) among the
three groups after 2 years.
2.4. Contact Lenses. The experimental SRRG lens designed
to produce peripheral myopic defocus was fitted after a
baseline examination that included refraction and corneal
measures obtained without refractive correction.The contact
lens was made of 2-hydroxy-ethyl methacrylate, a nonionic
material, with 38% water content and 12 units of oxygen
permeability (Dk) (Servilens, Granada, Spain). The central
thickness varied with optical power ranging from 0.09 to
0.14mm. The overall diameter was 14.00 to 15.00mm. The
base curve radius ranged from 8.00 to 8.90mm and was
calculated to be 0.7mm flatter than the average keratometric
radius. Experimental soft lenses have unique central back
and front optical zones of 8mm in diameter, and only the
central apical zone had the power required for distance vision.
The progressive design provided an increasing add power
that reached +2.00D add plus power, which corresponded to
about 35 degrees of retinal eccentricity and achieved about
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Table 1: Comparison of the baseline mean ± SD and gender proportion of all subjects initially included in the study, participants who
completed the study and those who left the study.
All Completed Discontinued
SRRG OK SV SRRG OK SV SRRG OK SV
Gender
(male; female) 11; 19 16; 13 20; 21 8; 11 10; 8 13; 8 3; 8 6; 5 7; 13
Age 13.07 ± 2.11 12.48 ± 1.50 13.06 ± 2.51 13.34 ± 1.95 12.27 ± 1.76 13.09 ± 2.79 12.21 ± 2.17 13.45 ± 1.07 12.88 ± 2.70
M (D) −3.76 ± 2.04 −3.44 ± 2.18 −3.11 ± 1.53 −4.46 ± 1.69 −3.51 ± 2.13 −3.61 ± 0.98 −3.62 ± 2.20 −2.86 ± 2.38 −2.03 ± 0.91
Flat 𝐾 (mm) 7.72 ± 0.21 7.86 ± 0.26 7.83 ± 0.23 7.67 ± 0.17 7.79 ± 0.30 7.81 ± 0.20 7.77 ± 0.25 7.85 ± 0.21 7.92 ± 0.28
Steep 𝐾 (mm) 7.57 ± 0.21 7.69 ± 0.27 7.71 ± 0.23 7.53 ± 0.17 7.62 ± 0.29 7.66 ± 0.21 7.62 ± 0.27 7.68 ± 0.21 7.81 ± 0.26
Eccentricity (𝑒) 0.48 ± 0.11 0.45 ± 0.08 0.53 ± 0.09 0.47 ± 0.11 0.44 ± 0.08 0.53 ± 0.08 0.49 ± 0.10 0.47 ± 0.08 0.51 ± 0.10
Pachymetry 542 ± 38 537 ± 18 542 ± 28 534 ± 29 538 ± 17 537 ± 24 559 ± 47 547 ± 32 547 ± 47
Anterior chamber 3.84 ± 0.27 3.85 ± 0.23 3.81 ± 0.29 3.84 ± 0.24 3.83 ± 0.19 3.85 ± 0.24 3.86 ± 0.25 3.84 ± 0.24 3.82 ± 0.34
Lens 3.47 ± 0.20 3.46 ± 0.18 3.51 ± 0.18 3.51 ± 0.19 3.53 ± 0.19 3.49 ± 0.19 3.39 ± 0.20 3.41 ± 0.10 3.54 ± 0.13
Vitreous chamber 17.08 ± 0.99 17.46 ± 0.95 17.04 ± 0.74 17.04 ± 0.91 17.23 ± 1.02 17.37 ± 0.83 17.24 ± 1.15 17.48 ± 0.78 16.76 ± 0.79
Axial length 24.38 ± 0.98 24.77 ± 0.89 24.36 ± 0.81 24.38 ± 0.90 24.58 ± 0.95 24.70 ± 0.87 24.46 ± 1.12 24.71 ± 0.71 24.11 ± 0.88
Table 2: Mean spherical equivalent increases and SD over 2 years in 6-month intervals. The previous annual increase is shown in the first
column. Statistically significant results are marked with an asterisk.
12 months before 6 months 12 months 18 months 24 months
Spherical equivalent changes (D)
SRRG −0.76 ± 0.27 −0.06 ± 0.21 −0.28 ± 0.38 −0.39 ± 0.39 −0.56 ± 0.51
OK −0.75 ± 0.25 −0.16 ± 0.20 −0.26 ± 0.44 −0.32 ± 0.43 −0.32 ± 0.53
SV −0.62 ± 0.25 −0.27 ± 0.13 −0.53 ± 0.25 −0.80 ± 0.40 −0.98 ± 0.58
Multiple comparisons contrast-𝑃
SV-SRRG 0.660 <0.0001∗ 0.010∗ 0.001∗ 0.010∗
SV-OK 0.130 0.137 <0.0001∗ <0.010∗ 0.030∗
SRRG-OK 0.550 0.092 0.163 0.790 0.965
+6.00D of addition plus power at the edge of the optical
zone (4mm semichord diameter). Contact lens fitting was
performed according to the subjective refraction, corneal
curvature, and visible iris diameter. The corneal topography
wasmeasured using theKeratron ScoutCorneal Topographer
(Opticon 2000 SpA, Rome, Italy). Adjustments to the final
prescription were based on spherical overrefraction, and a
new lens was ordered if discrepancies exceeding ±0.25D
were found. Fitting was assessed for centration and lag
on lateral gaze movements using the slit-lamp beam. All
lenses were within the desired limits of less than 0.50mm of
movement on blink in upgaze and 1.00mm lag in lateral gaze.
Measurements were obtained without correction in SRRG
and SV spectacle control groups.
The OK group was fitted with a Double Reservoir
Lens (DRL) (Precilens, Paris, France), previously calculated
according to themanufacturer’s protocols that considered the
topographic values and refraction. All fittings were optimized
until centration and the correct refractive outcomes were
achieved. DRL lenses are made of a Boston XO2 (hexafocon
B) material with an oxygen permeability of 141 barriers,
refractive index of 1.424, Rockwell R hardness of 101 units,
and wetting angle of 38 degrees measured with the captive
bubble method.
2.5. Primary Outcomes. The refractive error was measured in
0.01 D steps with cycloplegic autorefraction using the Grand
Seiko Autorefractometer/Keratometer WAM-5500 (Grand
Seiko Co., Ltd., Hiroshima, Japan), with the same protocol
used for all three groups.
Cycloplegia was achieved using two drops of cyclopen-
tolate 1% separated by 10 minutes each. The same examiner
performed and averaged five consecutive measurements 30
minutes after the second drop was instilled.
The refraction was adjusted using keratometric changes
from baseline to avoid any change in the anterior surface due
to a warpage effect from the soft lenses. In the OK group, the
refraction was measured over the OK lens during all visits,
with the lens centered between blinks, which is achieved
considering the diameter and fitting characteristics achieved
with the DRL.The keratometry values of the anterior contact
lens surface were assessed to assure that no lens flexure
occurred.
The AL was measured in 0.01mm steps under cyclo-
plegia obtained using cyclopentolate hydrochloride 1.0%
(Alcon, El Masnou, Spain) and anesthesia using oxybupro-
caine hydrochloride 0.4% and tetracaine hydrochloride 0.1%
(Alcon) using the OcuScan RxP Ophthalmic Ultrasound
System (Alcon, Fort Worth, TX, USA). Ecographic signals
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Table 3:Mean and SD of biometric changes (anterior chamber, lens,
vitreous chamber, and AL) during 2 years in 6-month increments.
Statistically significant results are marked with an asterisk.
6 months 12 months 18 months 24 months
Biometric changes (mm)
Anterior chamber depth (mm)
SRRG 0.04 ± 0.12 0.13 ± 0.14 0.13 ± 0.16 0.16 ± 0.18
OK 0.03 ± 0.04 0.05 ± 0.08 0.09 ± 0.09 0.11 ± 0.11
SV 0.08 ± 0.12 0.14 ± 0.20 0.17 ± 0.15 0.20 ± 0.17
Lens thickness (mm)
SRRG −0.01 ± 0.05 −0.02 ± 0.06 −0.01 ± 0.04 0.00 ± 0.06
OK 0.00 ± 0.02 0.01 ± 0.04 0.01 ± 0.05 0.02 ± 0.05
SV −0.02 ± 0.03 −0.04 ± 0.06 −0.03 ± 0.05 −0.02 ± 0.05
Vitreous chamber depth (mm)
SRRG 0.09 ± 0.09 0.15 ± 0.16 0.20 ± 0.14 0.23 ± 0.20
OK 0.05 ± 0.06 0.11 ± 0.13 0.16 ± 0.17 0.18 ± 0.21
SV 0.09 ± 0.09 0.18 ± 0.18 0.27 ± 0.22 0.34 ± 0.23
Axial length (mm)
SRRG 0.13 ± 0.11 0.26 ± 0.15 0.32 ± 0.19 0.38 ± 0.21
OK 0.08 ± 0.05 0.15 ± 0.10 0.24 ± 0.14 0.32 ± 0.20
SV 0.15 ± 0.09 0.28 ± 0.17 0.41 ± 0.22 0.52 ± 0.22
Multiple comparisons contrast P for axial length
SV-SRRG 0.206 0.800 0.163 0.070
SV-OK 0.02 0.005∗ 0.006∗ 0.008∗
SRRG-OK 0.214 0.003∗ 0.144 0.346
were examined for relatively equal lens peaks and properly
marked retinal peaks. The same experienced optometrist
performed 10 consecutive measurements. When poor signals
were detected, measures were repeated. The mean axial
dimensions were calculated as the mean of the 10 readings.
2.6. Other Measurements. The keratometry and corneal
eccentricity values were retrieved to analyze the longitudi-
nal corneal changes for the SRRG and SV lens. Corneal
pachymetry was performed before biometry using the same
instrument (OcuScan RxP) with the appropriate probe. The
relative peripheral refractive error (RPRE) was obtained at
30 degrees of the nasal and temporal retinal eccentricities at
baseline with soft contact lenses. The RPRE also was deter-
mined in the OK group before and after treatment stabiliza-
tion using the Grand Seiko Autorefractometer/Keratometer
WAM-5500.
2.7. Statistical Analysis. To analyze myopic progression for 1
year before and 6, 12, and 18 months, and 2 years of follow-up
after lens fitting, only the data from children who completed
the study were included. At the end of the treatment, 11
participants in the SRRG group were not included primarily
because eight were lost to follow-up, two had lens discomfort,
and one moved. In the OK group, one child had peripheral
inflammatory keratitis and left the study, three moved, and
seven were lost to follow-up. In the SV group, 20 patients
were lost to follow-up. All clinical conditions were treated
adequately and recovered without visual loss.
At the 2-year visit, 19, 18, and 21 eyes were included in the
final analysis in the SRRG, OK, and SV groups, respectively
(Figure 1).
All analyses were performed using the SPSS software
package version 19 (SPSS Inc., Chicago, IL, USA). The
Kolmogorov-Smirnov test was applied to assess the normality
of data distribution. Analysis of variance (ANOVA) and the
Kruskal-Wallis test were used for comparisons among all
compensation groups to assess differences among the SRRG,
OK, and SV groups for normally or nonnormally distributed
variables, respectively. The paired sample test and Wilcoxon
signed-ranks test were used for comparisons between two
different conditions (SRRG and SV, SRRG and OK, and SV
and OK) for normally or nonnormally distributed variables,
respectively. Spearman’s rho correlation was applied when
normality could not be assumed, and the Pearson correlation
was used when normal distribution of data was verified to
evaluate the relationship between refractive change and AL
change and the peripheral refractive error at baseline and
myopic change.
To evaluate the best eye biometric changes during the
study, we calculated the slope of the linear regression for the
changes in each individual in biometric parameters during
the 2-year evaluation (anterior chamber depth (ACD); lens
thickness (L); vitreous chamber depth (VCD); and AL). We
then performed nonparametric Kruskal-Wallis test to eval-
uate the significance of the intragroup slope. For statistical
purposes, 𝑃 < 0.05 was considered significant.
3. Results
3.1. Baseline Values. Table 1 shows the baseline data. No
significant (𝑃 > 0.05) differenceswere seen among the groups
in gender, age, M refractive error component, keratometry,
corneal eccentricity, pachymetry, ACD, lens thickness, vitre-
ous chamber, or AL.
3.2. RPRE Related to Myopia Increase. A small but significant
correlation was found between the baseline sphere and the
amount of M RPRE for the temporal and nasal retina (𝜌 =
−0.279; 𝑃 = 0.02; and 𝜌 = −0.223; 𝑃 = 0.05, resp.)
with higher central myopes also having higher degrees of
relative peripheral hyperopia. The baseline refractive sphere
was highly correlated with the amount of myopic progression
before baseline (𝜌 = 0.542; 𝑃 < 0.0001).
Significant correlations were found between the baseline
RPRE-M (RPRE as the spherical equivalent of refraction
“M”) at 30 degrees and the rate of myopic progression
during 1 year before baseline. The values were significantly
correlated at the temporal and nasal retina (𝜌 = −0.295,
𝑃 < 0.01; and 𝜌 = −0.254; 𝑃 < 0.05, resp.), suggesting
that higher degrees of peripheral hyperopia were associated
with greater central progression during 1 year before the
trial (Figure 2). No correlations were found between the
RPRE-J0 and RPRE-J45 (RPRE as the horizontal and oblique
astigmatic components of refraction “J0” and “J45,” resp.),
nasal or temporal, refraction components, and the myopic
increase during 1 year before the baseline evaluation.
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Enrollment 127 assessed for eligibility
Excluded:
27 low progression
30 allocated to SRRG 29 allocated to OK 41 allocated to SV
Follow-up
Analysis
19 analyzed 18 analyzed 21 analyzed
Excluded: 11
12-month
Lost to follow-up
Ocular health
problems
Comfort
problems
Move away
Total
visit
8
24-month
visit
12-month
visit
24-month
visit
12-month
visit
24-month
visit
0
0 0
2 0
1 0
11 0
Excluded: 11
Lost to follow-up
Ocular health
problems
Comfort
problems
Move away
Total
5 2
1 0
0 0
2 1
8 3
Excluded: 20
Lost to follow-up
Ocular health
problems
Comfort
problems
Move away
Total
16 4
0 0
0 0
0 0
16 4
Figure 1: Flow diagram of study progress in the SRRG, OK and SV groups.
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Figure 2: Increase in M from 1 year before treatment to baseline
related to the RPRE (M value at the temporal and nasal retina). The
values at the temporal and nasal retina are significant (𝑃 < 0.01 and
𝑃 < 0.05). Every 1.00D of hyperopic RPRE temporal M value is
related to a −0.10 D extra increase in annual M value. The dotted
line indicates the regression of the RPRE-T (temporal retina) and
the dashed line indicates the RPRE-N (nasal retina).
The RPRE also was measured at 30 degrees of the nasal
and temporal retinal eccentricities at baseline through the
experimental lens. No correlation was found between the
myopic RPRE-M measured with the SRRG at the nasal (𝑃 =
0.270) and temporal (𝑃 = 0.940) eccentricities and the
amount of refractive or AL change for the first year in the
SRRG group. Moreover, the baseline RPRE (M, J0, and J45)
was not correlated significantly with the myopia refractive
change at 1 year in this group. However, the RPRE-M at
the temporal and nasal retina measured in all participants
through the corresponding visual correction (soft experi-
mental lenses and glasses) was correlated with the increase in
the AL for the first year of treatment (RPRE-N, 𝜌 = −0.400;
𝑃 < 0.001 and RPRE-T, 𝜌 = −0.241; 𝑃 < 0.05) (Figure 3).
3.3. Spherical Equivalent: Changes at 6, 12, 18 Months and
2 Years. All groups had similar rates of progression over
the year before recruitment. The mean values were −0.62 ±
0.25D/year, −0.75 ± 0.25D/year, and −0.76 ± 0.27D/year for
the SV, OK and SRRG groups, respectively (𝑃 = 0.156). The
SV group had higher changes in spherical equivalent (M)
than the SRRG and OK groups during the full length of the
study. After 2 years, the mean rates of myopic progression
for the SRRG, OK, and SV groups were −0.56 ± 0.51D,
−0.32±0.53D, and−0.98±0.58D, respectively.This represents
a reduction in myopic progression of 43% and 67% for the
SRRG and OK groups, respectively, compared to the SV
group. The difference, although larger in the OK group, did
not differ significantly (𝑃 = 0.163) from the SRRG group.
Table 2 and Figure 4 show the mean myopic progression for
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Figure 3: AL increase in relation to the RPRE in the nasal and
temporal retina measured through the SRRG (experimental group)
and SV (control group). The black diamonds indicate the RPRE-
T (temporal retina); the grey squares indicated the RPRE-N (nasal
retina); the dotted line indicates the regression of the RPRE-T; and
the dashed line indicates the RPRE-N.
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Figure 4:Mean and SD ofmyopic progression (spherical equivalent
refraction).
the three groups at each 6-month interval for the 2 years of
the study.
3.4. The Biometric Changes at 6, 12, 18 Months and 2 Years.
The AL increased more in the SV group compared to the
SRRG and OK groups, respectively; the difference between
the SRRG and SV groups was not significant and only
approached statistical significance at 2-year visit (𝑃 = 0.08).
The increase in AL in the OK group was significantly lower
at all visits compared to the SV group. The mean increases in
AL at 2 years were 0.38±0.21mm, 0.32±0.20mm, and 0.52±
0.22mm for the SRRG, OK, and SV groups, respectively. In
other words, the AL in the SRRG and OK groups increased
0
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Figure 5: Mean and SD of AL progression (mm).
27% and 38% less than in the SV group over 2 years. The
results are listed in Table 3 and plotted in Figure 5.
The ACD changes at 2 years were 0.16 ± 0.18mm, 0.11 ±
0.11mm, and 0.20 ± 0.17mm for SRRG, OK, and SV groups,
which corresponded to 20% and 45% lower increases in the
ACD in the SRRG andOK groups compared to the SV group.
The differences did not reach significance at any visit.
Crystalline lens biometry did not change in the SRRG
group. There was a small increase in the OK group (0.02 ±
0.05mm) that was significant at 12 and 18 months and 2 years
(𝑃 < 0.05) and a slight decrease in thickness in the SV group
(−0.02 ± 0.05mm).
The vitreous chamber increased by 0.23±0.20mm, 0.18±
0.21mm, and 0.34 ± 0.23mm in the SRRG, OK, and SV
groups, respectively, which corresponded to a 32% lower
increase in the SRRG group and a 47% lower increase in
the OK group compared to the SV group. The differences
obtained at 6, 12, and 18 months and 2 years were not signifi-
cant (Figure 6). Table 3 shows the results for all parameters.
3.5. Slopes of the Progression Lines. The coefficient of deter-
mination 𝑟2 of the regression lines resulted in 0.83, 0.99, and
0.98 for the SRRG, OK, and SV groups, respectively. The
AL growth slope was significantly higher in the SV group
compared with the SRRG and OK groups (𝑡: 147, 𝑃 < 0.05
and 𝑡: 141, 𝑃 = 0.02 for the SRRG and OK groups versus
the SV group, resp.). The SRRG and OK groups did not
differ significantly (𝑡: 127; 𝑃 = 0.430). The median slopes
were 0.016 (95% confidence interval (CI); 0.010–0.017), 0.014
(95% CI, 0.009–0.018), and 0.022 (95% CI, 0.015–0.025),
indicating a calculated axial growth of 0.18mm/year (95%
CI, 0.123–0.210), 0.16mm/year (95% CI, 0.115–0.216), and
0.26mm/year (95% CI, 0.185–0.305) for the SRRG, OK, and
SV groups, respectively.
The VCD change slope was significantly lower for the
SRRG and OK groups compared to the SV group (𝑡: 161,
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Figure 6: Mean and SD of the VCD changes (mm).
𝑃 < 0.01 and 𝑡: 130, 𝑃 = 0.05 for the SRRG and OK
groups versus the SV group, resp.). The SRRG and OK
groups did not differ significantly (𝑡: 119; 𝑃 = 0.154).
The median slopes were 0.009 (95% CI, 0.004–0.010), 0.008
(95% CI, 0.004–0.012), and 0.012 (95% CI, 0.009-0.017). This
represents an estimated VCD growth of 0.10mm/year (95%
CI, 0.061–0.136), 0.09mm/year (95% CI, 0.052–0.151), and
0.15mm/year (95% CI, 0.115–0.214) for the SRRG, OK, and
SV groups, respectively.
Differences in the slope of crystalline lens changes were
not significant in any comparison (𝑡: 114, 𝑃 = 0.229; 𝑡: 149,
𝑃 = 0.855 for the SRRG and OK groups compared to the
SV group, respectively;, and 𝑡: 169, 𝑃 = 0.747 for the SRRG
group compared to the OK group). The ACD changes were
not significant for any combination: 𝑡: 182, 𝑃 = 0.898; 𝑡:
160, 𝑃 = 0.458, for the SRRG and OK groups versus the SV
group, respectively; and 𝑡: 107, 𝑃 = 0.956, for the SRRG group
compared with the OK group.
Correlation analysis between axial elongation and base-
line refraction showed aweak correlation for either treatment
or control groups (𝜌 < 0.300; 𝑃 < 0.05) suggesting that the
efficacy of the treatment could not be anticipated as a function
of the baseline refraction.
3.6. Corneal Parameters. The topographic and pachymetric
parameters did not change significantly during the trial
between the SRRG and SV groups. However, the mean
keratometric reading changed in the SRRG group from 7.60±
0.16mm to 7.56 ± 0.16mm and pachymetry changed from
534 ± 29 microns to 542 ± 27 microns at 6 months and
then returned to 537±32microns.The eccentricity remained
almost unchanged during the study in all groups.
4. Discussion
Both the SRRG and OK groups slowed progression of the
refractive error by about 43% and 67%, respectively, and they
slowed the ocular growth by about 27%and 38%, respectively;
nonetheless, this biometric data did not reach significance.
While the SV group maintained the same rate of myopia
progression throughout the 2 years of the study as before the
study, the SRRG and OK groups showed a clear change in
the refractive pattern after treatment by slowing the rate of
myopic progression in both groups.
The main limitation of the current study was the small
number of subjects who completed the study. In a recent
study that evaluated the differences in myopia progression
with a multifocal contact lens, Walline et al. [22] reported the
outcomes of 27 of 40 subjectswho completed the 2-year study.
Although our dropout rate was high (∼42%), it is similar
to that in another recent study of DISC lenses [19], and
it was similarly distributed in the three groups. Further,
the differences between groups were higher than those we
initially expected. Therefore, we still maintained a statistical
power of 80% to detect differences of 0.75D and 0.20mm in
refractive changes and axial elongation between the SV group
and the other groups with a minimum of 10 subjects in each
group. Despite this, further studies with more patients are
necessary to confirm the current results.
Our findings supported the myopic progression control
effect reported in previous studies of soft multifocal center-
distance contact lenses [18, 19, 21]. The mechanism of the
effect still needs to be determined with a long-term random-
ized clinical trial, but it seems clear that peripheral refraction
has a potential role. Sankaridurg et al. [18] reported a sig-
nificant correlation between RPREmeasured with multifocal
lenses at 30 and 40 degrees in the nasal and temporal retina
and progression of myopia. We failed to find a significant
correlation between the RPRE (nasal and temporal) and
sphere equivalent or AL increase in the SV and SRRG
groups probably due the small size sample. However, when all
subjects were considered, we found a significant correlation
between theRPRE-MandAL change for the first year, and the
regression line showed a trend for an inverse relation between
a lower refractive increase and more myopic defocus in the
nasal and temporal eccentricities. Refractive progression dur-
ing the year before the trial was correlated with the RPRE at
baseline for both retina eccentricities, suggesting that higher
degrees of peripheral hyperopia were associated with greater
central progression during 1 year before the trial.The baseline
sphere also was correlated significantly with the RPRE in the
nasal and temporal retina and the amount of baseline sphere
was correlated with the amount of progression before the
trial, which agreed with the outcome that the nasal retina
seems to be related more to myopic progression [25] and
relative peripheral hyperopia associated with the amount of
central myopia [26]. Nevertheless, in a large population-
based cohort study, Mutti et al. [27] showed that the RPRE
was not associated with the risk of axial elongation and they
concluded that it seemed to exert little consistent effect on
the risk of onset of myopic refractive error. Moreover, in a
recent study, the baseline relative peripheral hyperopia was
not associated with a greater likelihood of becoming myopic
ormyopia progression [28]. In the current sample, all subjects
were myopes with a minimal progression of 0.30D/year,
and the relationship between the RPRE with the refractive
correction was correlated with the amount of increase in
the AL after 1 year of treatment. More research is needed to
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elucidate the relationship between the hyperopic RPRE and
the likelihood of progression.
Another potential limitation was the measurement of
the biometric data done with ultrasonography that requires
contact with the eye. This should not be problematic in the
hands of an experienced technician. Further, this instrument
allowed us to obtain partial measures of the anterior and
posterior dimensions of the eye in addition to the crystalline
lens thickness. Biometric data such as the ACD change failed
to reach significance, although there was a lower increase
by 45% in the OK group and by 20% in the SRRG group
compared with the SV group. The lens thickness increased
slightly in the OK group after 2 years (0.02mm); although it
was significant, it may have resulted from increased corneal
aberrations [29]. The changes were small and more investi-
gation is needed. The vitreous chamber increased less in the
SRRG and OK groups compared with the SV group, that is,
about 32% and 47%, respectively, but it was not significant at
any visit.
We do not know why the refractive change slowed twice
as much as the axial increases. A possible limitation of
the study was less precise measurement of axial elongation
with A-scan ultrasonography compared to partial coherence
interferometry. Ultrasound biometry had been largely used
in longitudinal studies of myopia in children as in the
CLEERE [30] and COMET [8] studies. Although A-scan
ultrasonography is considered sensitive to changes in the AL
and VCD equivalent to 0.25D, it may be a useful technique
to assess changes in ocular components in children [31].
In addition, during the study, the measurement methods
did not vary and one expert optometrist performed all
measurements. Regardless of the fact that wemay not discard
an excess of pressure when data was acquired, the VCD
also remained nonsignificant. A recent study over a 3-year
period onmyopia control withOK also showed discrepancies
between the refractive and biometric results. Although the
OK group progressed −0.12D and the control (soft lens)
group progressed −1.01 D, the outcomes failed to show AL
differences measured by ultrasound between the test and
control groups. The authors explained that this finding was
due to the high variability between the multiple sites of
acquisition [32]. In our case, one expert examiner collected
the data using the same procedure and instrument. One
possible cause of the bias may be the ethnicity of the sample.
All the children that participated to the studywereCaucasian.
Previous studies found a similar difference. For example
Walline et al. [22] performed a study of myopic control with
a soft multifocal contact lens and obtained changes of 29%
and 50% for AL and refractive increases, respectively, and
OK results reported by Santodomingo-Rubido et al. [33]
showed a 32% reduction effect on AL growth, which is much
lower than the normal control effect values reported with
OK in Asian children (∼50%). Caucasian children have a
lower ratio ofmyopia/AL increase than Asian children. In the
CLEERE study [30], the differences in AL growth between
emmetropic and myopic children were 0.21mm/year for the
Asian children compared with 0.14mm/year for the Cau-
casian children. Moreover, in emmetropic children the AL
increased steadily by about 0.10mm/year compared with the
myopic sample at 0.31mm/year [30].Thismeans that a 2-year
increase in AL for emmetrope is roughly 0.20mm. Hence,
it is illogical to calculate the percentage of myopia control
without previously subtracting the emmetropic normal rate
of AL growth in all samples. Moreover, seven children were
not included in the study due to a low myopia increase and
finished the 2-year visit with a refractive change of −0.09 ±
0.27D and an AL change of 0.19 ± 0.14mm. In our case, the
AL increase after subtraction of the emmetropic children eye
grow resulted in 0.18mm in the SRRG group and 0.32mm in
the SV group. Those results represent 43% and 62%, which is
much more in agreement with the refractive results.
Keratometry and pachymetry did not show any sig-
nificant changes during the study in any group. In fact,
the keratometric variations were considered to readjust the
refractive changes from baseline values to avoid confusing
results due to anterior corneal changes induced by the soft
contact lenses. A limitation of this study was the fact that the
uncorrected refractive state of the OK group over the 2 years
of the study was impossible to measure due to the induced
corneal changes. For this reason, the refractive values in the
OK group were evaluated with the lenses on, and to avoid
possible lens deformation a final value was adjusted after the
power changes of the anterior optical surface of the lens.
Despite the fact that we did not find significant differences
between the direct data of the VCD and AL for the SRRG and
SV groups, the comparison of the slopes of ocular growth
provided clear differences. The slope of the regression line
showed the rate of ocular change for each component. This
may be a reliable and novelmethod to analyze ocular changes,
and thus it may be useful in future studies of myopia control
and ocular growth, leading to a clear understanding of the
speed of the ocular changes for each component. The VCD
and lens thickness increased similarly among all participants
irrespective of their group. The VCD and AL showed similar
results, meaning that both variables are well correlated and
this eliminates the possibility of a shortened AL by excess
pressure, and hence a reduced ACD, at the time of data
collection.
OK is currently considered the best optical correction
system for myopic control [14, 34]. Studies have shown that
the effect on AL growth retention is between 30% and 63%
compared to the SV lens or a monofocal contact lens. In this
study, we failed to find a decrease in AL growth exceeding
30%. Both the SRRG andOKgroups showed a similarmyopic
control effect after 2 years, which suggests that the SRRG lens
was comparable in this study toOK regarding theAL growing
control effect. This effect was consistent during the 2 years of
the study. Although the refractive retention effect was better
in the OK group with respect to the SRRG group (67% and
43%, resp.), the SRRG lens seems to be a promising optical
device that may help to control myopia in children.
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